Epsilon Healthcare Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Daniel Sanghera
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.4yrs |
| Board average tenure | 1.6yrs |
Recent management updates
Recent updates
CEO
Daniel Sanghera
less than a year
Tenure
Mr. Daniel Sanghera is General Manager of Epsilon Pharma and has been Interim Chief Executive Officer at Epsilon Healthcare Limited since November 2023.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.6yrs | no data | no data | |
| Chief Operating Officer of Tetra Health | 3.9yrs | no data | no data | |
| Interim Chief Executive Officer | less than a year | no data | no data | |
| Group Financial Controller | 1.4yrs | no data | no data | |
| Company Secretary | 1.4yrs | no data | no data |
1.4yrs
Average Tenure
Experienced Management: HDRP.F's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 1.6yrs | no data | no data | |
| Non-Executive Deputy Chairman | 1.7yrs | no data | 3.5% A$ 165.9k | |
| Non-Executive Director | 1.6yrs | no data | 2.81% A$ 133.3k |
1.6yrs
Average Tenure
Experienced Board: HDRP.F's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.